A Study in Patients With Atopic Eczema to Test How Effective BI 655130 is and How Well it is Tolerated
Clinical trial NCT03822832 · COMPLETED
Trial details
- NCT number
- NCT03822832
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-12
- Primary completion
- 2020-01-17
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.